Boai NKY Pharmaceuticals is a company operating in the pharmaceutical industry.
Boai NKY Pharmaceuticals Ltd (NKY, stock code: 300109) is publicly traded company on the Shenzhen stock exchange, the first domestic company to develop and manufacture PVP and PVM/MA products, the 3rd largest Global PVP manufacturer; Our product, KoVidone(R) and PolyKoVidone(R) line of products representing Povidone, Crospovidone and Copovidone pharmaceutical excipients. KoVidone(R)-I (PVP-I) broad spectrum biocidal, antifungal and antiviral agent. OraRez(R) line of PVM/MA Copolymer and derivatives respresenting functional polymers for bioadhesive/mucoadhesive applications.
Company type
Products and services
Excipients, Pharmaceutical Packaging
Markets
Oceania, North America (USA, Canada), Africa, Middle East Region (e.g. UAE), Central America (e.g. Mexico), East Asia (e.g. China, Japan, Korea), Europe – EU countries, Europe – non EU (e.g. UK, Russia, ex-CIS countries), South America (e.g. Brazil, Colombia), South Asia (e.g. India, Pakistan, Sri Lanka), South East Asia (e.g. Thailand, Philippines, Singapore)
Useful Links
Connect with Boai NKY Pharmaceuticals on LinkedIn
Address
Boai NKY Pharmaceuticals, No.1888 Wenhua Road, Boai, Jiaozuo,, Henan, China, 454450
Stay ahead of trends and best practices
